Histologic margin involvement by cutaneous basal cell carcinoma stroma: a retrospective cohort study for residual or recurrent carcinoma
- 23 January 2026
- journal article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 79 (4) , 245-249
Abstract
Aim: The clinical significance of histologic margin involvement by basal cell carcinoma (BCC)-associated stroma remains uncertain. This study aimed to determine the incidence of residual BCC in immediate re-excision specimens or clinical recurrence in cases managed without re-excision. Methods: Fifty-eight cases of BCC with stromal margin involvement diagnosed between 2016 and 2020 were retrospectively reviewed. Fifty cases underwent immediate surgical re-excision, and eight were managed with clinical observation for at least two years. Tumors were classified by histologic subtype, and stromal margin involvement was categorized as peripheral, deep, or both. Residual carcinoma on re-excision or clinical recurrence within two years was recorded. Results: Residual carcinoma was identified in 8% of re-excised cases (4/50) and occurred exclusively in tumors with a superficial component, including three pure superficial BCCs and one mixed superficial-nodular BCC; all residual tumors were of superficial subtype. No residual carcinoma was observed among 23 nodular or infiltrative BCCs that underwent re-excision. None of the eight cases managed with observation (1 superficial, 2 mixed superficial-nodular, 5 nodular) demonstrated clinical recurrence within two years. Overall, residual or recurrent disease occurred in 7% of cases (4/58). The distribution of adverse outcomes differed significantly by histologic subtype. Conclusions: Stromal margin involvement in non-superficial BCCs is rarely associated with residual or recurrent carcinoma. Adverse outcomes were confined to tumors containing a superficial component, highlighting biologic heterogeneity among BCC subtypes. These findings suggest that routine re-excision may be unnecessary for stromal-margin-positive BCCs lacking a superficial component and support more selective, subtype-informed management.Keywords
This publication has 11 references indexed in Scilit:
- The emerging roles of Hedgehog signaling in tumor immune microenvironmentFrontiers in Oncology, 2023
- Nodular and Micronodular Basal Cell Carcinoma Subtypes Are Different Tumors Based on Their Morphological Architecture and Their Interaction with the Surrounding StromaDiagnostics, 2022
- Guidelines of care for the management of basal cell carcinomaJournal of the American Academy of Dermatology, 2018
- Accuracy of biopsy sampling for subtyping basal cell carcinomaJournal of the American Academy of Dermatology, 2012
- Stromal fibroblasts from basal cell carcinoma affect phenotype of normal keratinocytesBritish Journal of Dermatology, 2007
- Increased Glycosaminoglycans Production in Sclerosing Basal Cell Carcinoma-Derived Fibroblasts and Stimulation of Normal Skin Fibroblast Glycosaminoglycans Production by a Cytokine-Derived from Sclerosing Basal Cell CarcinomaDermatologic Surgery, 2000
- Identification of the origin of cells in human basal cell carcinoma xenografts in mice using in situ hybridizationBritish Journal of Dermatology, 1989
- Recurrence rate of positive margin basal cell carcinoma: Results of a five‐year prospective studyJournal of Surgical Oncology, 1985
- PROGNOSIS OF “INCOMPLETELY EXCISED” VERSUS “COMPLETELY EXCISED” BASAL CELL CARCINOMAPlastic and Reconstructive Surgery, 1968
- Significance of Marginal Extension in Excised Basal-Cell CarcinomaNew England Journal of Medicine, 1965